The DM Quatro™ are four (4) individual FDA Cleared tools that assess the autonomic nervous system (ANS), diabetic retinopathy (DR), diabetic peripheral neuropathy (DPN), and peripheral arterial disease (PAD). 

The DM Quatro™ are medical devices with the following features: 

• Measurement of Retina of the Eyes (DR)

• Measurement of Peripheral Artery Disease (PAD)

• Measurement of the Sympathetic Skin Response (SSR) for the sudomotor function testing (small fiber) 

• Measurement of the Sympathetic Skin Response (SSR) for the loss of protective sensation (large fiber)

• Measuring the Autonomic Nervous System (ANS) via Heart Rate Variability

Diabetic Retinopathy Exam www.DMeyes.org Diabetic Retinopathy is an eye condition that can cause vision loss and blindness in people and should not be confused with an ophthalmoscope eye exam. 50% of diabetic patients lack documentation of a retinal eye exam which is the most difficult HEDIS measure to meet. Therefore, insurance companies are grateful for assistance to close the gap in care.

Diabetic Neuropathy Device™ www.DPNtest.org is the First FDA Cleared Multi-Objective Innovation that Identifies, and Measures Peripheral Neuropathy. 

Autonomic Nervous System (ANS) www.ANStest.org device is FDA Cleared and Measures Arterial Stiffness, Vascularization, and Endothelial Function.

TruPAD™ www.TruPAD.org is a medical device that measures Peripheral Artery Disease (PAD), a condition in which the large and medium-sized arteries supply blood to the legs and become narrow or clogged with plaque, constricting blood flow. 

Features of the tests:

• Non-Invasive

• <3-minutes each to complete

• FDA Cleared with recommended billing codes

• Easy to interpret color-coded reports

• Allows provider to perform and bill for up to 4 billing codes